NCT04106258View on ClinicalTrials.gov

A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 27, 2020

Primary Completion Date

February 15, 2023

Study Completion Date

February 15, 2023

Conditions
Port-wine Stain
Interventions
DRUG

Hemoporfin PDT

Photodynamic therapy is performed using hemoporfin under general anesthesia. Hemoporfin（5mg/kg）is infused for 20 minutes, followed by light illumination at 10 minutes from the start of infusion. Different light dose of PDT is applied to the patients.

Trial Locations (1)

200011

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT04106258 - A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain | Biotech Hunter | Biotech Hunter